Advertisement

Biologic and Physical Principles of Total Body Irradiation for Allogeneic and Autologous Bone Marrow Transplantation in Children with Leukemia and Lymphoma

  • Richard G. Evans
Part of the Medical Radiology book series (MEDRAD)

Abstract

Following Roentgen’s discovery of x-rays in the twilight of the nineteenth century, only a decade or so elapsed before the birth of total body irradiation (TBI), described by Dessauer in 1907 as the “x-ray bath.” In 1927, Teschendorf first described the favorable results he had achieved using TBI in the treatment of the lymphomas. Five years later, Heublein reported on a group of patients with lymphoma, Hodgkin’s disease, and leukemia treated with TBI at Memorial Hospital in New York. In the 1990s, we are still struggling with the nuances of TBI and, in particular, how it is best used in conditioning regimens for bone marrow trasplantation (BMT). The relatively new art of BMT remains fraught with complex issues, and the increasing use of and lymphomas and its emerging role in the treatment of solid tumors have led to a reexamination of the effects of various conditioning regimens, not only in terms of tumor cell kill and prevention of rejection, but also in relation to long-term organ toxicity. Prior to receiving TBI as part of their conditioning regimens for BMT, children have often been exposed to various agents such as cyclophosphamide and cisplatin, causing subclinical damage to such organs as kidney and lung which must be factored into considerations of long-term organ toxicity.

Keywords

Acute Lymphoblastic Leukemia Dose Rate Conditioning Regimen Total Body Irradiation Dose Fractionation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barendsen GW (1982) Dose fractionation, dose rate and isoeffects: relationships for normal-tissue responses. Int J Radiat Oncol Biol Phys 8: 1981–1997PubMedCrossRefGoogle Scholar
  2. Berg U, Bolme P (1989) Renal function in children following bone marrow transplantation. Transplant Proc 21: 3092–3094PubMedGoogle Scholar
  3. Collis CH, Steel GG (1983) Lung damage in mice from cyclophosphamide and thoracic irradiation: the effect of timing. Int J Radiat Oncol Biol Phys 9: 685–689PubMedCrossRefGoogle Scholar
  4. Corvo R, Frassoni F, Franzone P et al. (1989) Irradiazione corporea totale frazionata e iperfrazionata nel condizionamento del trapianto di midollo osseo allogenico nella leucemia linfatica acuta. Risultati. Radio Med (Torino) 78: 367–372Google Scholar
  5. Cosset JM, Baume D, Pico JL et al. (1989) single-dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a nonrandomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol 15: 151–160Google Scholar
  6. DeBoer RW, Lebesque JV (1988) Radiobiological implications of fractionated low dose rate irradiation. Int J Radiat Oncol Biol Phys 14: 1054–1056PubMedCrossRefGoogle Scholar
  7. Fowler JF (1989) The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62: 679–694PubMedCrossRefGoogle Scholar
  8. Kimler BF, Park CH, Yakar D, Mies RM (1984) Lack of recovery from radiation-induced sublethal damage in human hematopoietic cells. Br J Cancer 49 [Suppl VI]: 221–225Google Scholar
  9. Kimler BF, Park CH, Yakar D (1985) Radiation response of human hemopoietic cells (normal and leukemic) assayed by in vitro colony formation. Int J Radiat Oncol Biol Phys 11: 809–816PubMedCrossRefGoogle Scholar
  10. Lawton CA, Barber-Derus S, Murray KJ, Casper JT, Ash RC, Gillin MT, Wilson JF (1989) Technical modifications in hyperfractionated total body irradiation for T-lymphocyte depleted bone marrow transplant. Int J Radiat Oncol Biol Phys 17: 319–322PubMedCrossRefGoogle Scholar
  11. Moulder JE, Fish BL, Holcenberg JS, Cheng M (1988) Effect of total-body irradiation with bone marrow transplantation on toxicity of cisplatin. In: Interaction of radiation therapy and chemotherapy. NCI Monogr 6: 29–33Google Scholar
  12. Stewart FA, Luts A, Oussoren Y, Begg AC, Dewit L, Bartelink H (1988) Renal damage in mice after treatment with cisplatin and X-rays: comparison of fractionated and single-dose studies. In: Interaction of radiation therapy and chemotherapy. NCI Monogr 6: 23–27Google Scholar
  13. Tarbell NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ (1988) Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 15: 99–104PubMedCrossRefGoogle Scholar
  14. Thames HD, Hendry JH (1987) Fractionation in radiotherapy. Taylor and Francis, LondonGoogle Scholar
  15. Travis EL, Pouzet M-T, Yan R, Fang M-A (1990) Radiation response of mouse lung previously treated with cyclophosphamide: single dose and fractionation response. Third International Conference on the Interaction of Radiation Therapy and Systemic Therapy, 9–12 March 1990. The Asilomar Conference Center, Monterey, California, pp 4–2 through 4–2CGoogle Scholar
  16. Turesson I, Thames HD (1989) Repair capacity and kenetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 years’ follow-up. Radiother Oncol 15: 169–188PubMedCrossRefGoogle Scholar
  17. van Dyk J, Mah K, Keane TJ (1989) Radiation-induced lung damage: dose-time-fractionation considerations. Radiother Oncol 14: 55–69PubMedCrossRefGoogle Scholar
  18. Yan R, Peters LJ, Travis EL (1991) Cyclophosphamide 24 hours before or after total body irradiation: effects on lung and bone marrow. Radiother Oncol 21: 149–156PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • Richard G. Evans
    • 1
  1. 1.Department of Radiation OncologyUniversity of Kansas Medical CenterKansas CityUSA

Personalised recommendations